Close Menu

    Subscribe to Updates

    Get the latest creative news from Healthradar about News,Health and Gadgets.

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    What's Hot

    Signos Launches First FDA-Cleared Glucose Monitoring System for Weight Management

    9. September 2025

    77-year-old man developed phobia of mail during pandemic which caused him to miss violation warnings from HOA. Now he is fighting foreclosure

    9. September 2025

    Living Optics and NVIDIA Jetson Showcase Real-Time Hyperspectral Imaging

    8. September 2025
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest Vimeo
    healthradar.nethealthradar.net
    • Home
    • Ai
    • Gadgets
    • Health
    • News
    • Contact Us
    Contact
    healthradar.nethealthradar.net
    Home»News»Signos Launches First FDA-Cleared Glucose Monitoring System for Weight Management
    News

    Signos Launches First FDA-Cleared Glucose Monitoring System for Weight Management

    HealthradarBy Healthradar9. September 2025Keine Kommentare2 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Signos Launches First FDA-Cleared Glucose Monitoring System for Weight Management
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Signos Launches First FDA-Cleared Glucose Monitoring System for Weight Management

    What You Should Know: 

    – Signos, a metabolic and weight management company, has announced the launch of the Signos Glucose Monitoring System. 

    – The system is the first FDA-cleared, over-the-counter glucose monitoring system for weight management. It is also the first non-pharmacological approach cleared by the FDA for glucose management that not only helps those who are overweight but also helps prevent those who are at-risk.

    Enterprise-Grade Capabilities, Consumer-Friendly Experience

    In the U.S., nearly 74% of Americans are overweight or obese, and 88% are metabolically unhealthy, which fuels conditions like type II diabetes, prediabetes, and hypertension. The Signos system is designed to address this by using real-time data to show how a user’s lifestyle impacts their health. It then guides them to make small, sustainable changes.

    The Signos system integrates hundreds of millions of data points with each user’s unique profile and is paired with Stelo by Dexcom and Signos’ proprietary AI. The system shows how food, activity, stress, and sleep affect the body in real-time. This combination of precision health and a user-friendly experience is designed for easy adoption, measurable outcomes, and scalable impact.

    The system offers several key benefits for different stakeholders:

    • For Employers and Health Plans: They can monitor adoption, adherence, and outcomes instantly, which eliminates guesswork and waste. The solution works alongside GLP-1s or other programs and is a turnkey deployment that requires no integrations and can be rolled out in weeks.
    • For Insurance Carriers: They can lower chronic disease costs with proactive, preventative tools that are supported by real-time population-level data.
    • For Clinical Partners: They can access real-time patient data to reinforce healthy decisions between visits.

    Availability
    The Signos Glucose Monitoring System is available now. For enterprise and partnership inquiries, visit signos.com/business.



    Source link

    FDAcleared Glucose Launches Management Monitoring Signos system Weight
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous Article77-year-old man developed phobia of mail during pandemic which caused him to miss violation warnings from HOA. Now he is fighting foreclosure
    ekass777x
    Healthradar
    • Website

    Related Posts

    News

    Living Optics and NVIDIA Jetson Showcase Real-Time Hyperspectral Imaging

    8. September 2025
    News

    Amazon Pharmacy Expands RxPass to Texas, Offering $5 Monthly Prescriptions for Chronic Conditions

    8. September 2025
    News

    Senseonics inks deal to bring CGM commercialization back in-house

    8. September 2025
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    Garmin Venu 4: Everything we know so far about the premium smartwatch

    7. August 202562 Views

    The Top 3 Tax Mistakes High-Earning Physicians Make

    7. August 202523 Views

    Linea Expands AI-Powered Heart Failure Care Solution

    6. August 202519 Views

    Neurode wants to treat and track ADHD symptoms through a wearable headband

    1. Juni 20259 Views
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews

    Subscribe to Updates

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    About Us

    Welcome to HealthRadar.net — your trusted destination for discovering the latest innovations in digital health. We are dedicated to connecting individuals, healthcare professionals, and organizations with cutting-edge tools, applications

    Most Popular

    Garmin Venu 4: Everything we know so far about the premium smartwatch

    7. August 202562 Views

    The Top 3 Tax Mistakes High-Earning Physicians Make

    7. August 202523 Views
    USEFULL LINK
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    QUICK LINKS
    • Ai
    • Gadgets
    • Health
    • News
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    Copyright© 2025 Healthradar All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.